Haruyasu Ito

847 total citations
29 papers, 631 citations indexed

About

Haruyasu Ito is a scholar working on Cardiology and Cardiovascular Medicine, Epidemiology and Rheumatology. According to data from OpenAlex, Haruyasu Ito has authored 29 papers receiving a total of 631 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Cardiology and Cardiovascular Medicine, 9 papers in Epidemiology and 8 papers in Rheumatology. Recurrent topics in Haruyasu Ito's work include Inflammatory Myopathies and Dermatomyositis (5 papers), Cardiovascular Function and Risk Factors (4 papers) and Cardiovascular Effects of Exercise (3 papers). Haruyasu Ito is often cited by papers focused on Inflammatory Myopathies and Dermatomyositis (5 papers), Cardiovascular Function and Risk Factors (4 papers) and Cardiovascular Effects of Exercise (3 papers). Haruyasu Ito collaborates with scholars based in Japan, Italy and Germany. Haruyasu Ito's co-authors include Akira Matsumori, Shigetake Sasayama, Makoto Kinoshita, Yukihito Sato, Kazuaki Kataoka, Tasuku Yamada, Takeru Makiyama, Ryoji Taniguchi, Kozo Nagai and Hideshi Okada and has published in prestigious journals such as Circulation, Journal of the American College of Cardiology and Scientific Reports.

In The Last Decade

Haruyasu Ito

26 papers receiving 614 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Haruyasu Ito Japan 12 337 185 93 90 57 29 631
Mitsunori Ishino Japan 16 356 1.1× 205 1.1× 95 1.0× 59 0.7× 39 0.7× 26 664
Toyoharu Oba Japan 9 217 0.6× 135 0.7× 73 0.8× 120 1.3× 67 1.2× 15 474
Koba Kupreishvili Netherlands 8 563 1.7× 150 0.8× 110 1.2× 85 0.9× 50 0.9× 13 836
Shiping Cao China 15 197 0.6× 224 1.2× 109 1.2× 89 1.0× 56 1.0× 28 593
Jørgen Gravning Norway 13 329 1.0× 236 1.3× 97 1.0× 47 0.5× 27 0.5× 24 618
Т. Е. Суслова Russia 9 261 0.8× 141 0.8× 107 1.2× 72 0.8× 28 0.5× 87 491
Arnold Piek Netherlands 8 250 0.7× 158 0.9× 65 0.7× 44 0.5× 25 0.4× 9 489
Nerea Hermida Spain 11 391 1.2× 351 1.9× 161 1.7× 39 0.4× 44 0.8× 17 804
Promporn Suksaranjit United States 12 374 1.1× 73 0.4× 104 1.1× 119 1.3× 55 1.0× 31 687
Atai Watanabe Japan 15 307 0.9× 381 2.1× 69 0.7× 50 0.6× 61 1.1× 24 690

Countries citing papers authored by Haruyasu Ito

Since Specialization
Citations

This map shows the geographic impact of Haruyasu Ito's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Haruyasu Ito with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Haruyasu Ito more than expected).

Fields of papers citing papers by Haruyasu Ito

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Haruyasu Ito. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Haruyasu Ito. The network helps show where Haruyasu Ito may publish in the future.

Co-authorship network of co-authors of Haruyasu Ito

This figure shows the co-authorship network connecting the top 25 collaborators of Haruyasu Ito. A scholar is included among the top collaborators of Haruyasu Ito based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Haruyasu Ito. Haruyasu Ito is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shimojo, Takashi, Naoaki Onishi, Yohei Kobayashi, et al.. (2025). Conservative Management for Left Atrial Intramural Hematoma After Cryoballoon Ablation. JACC Case Reports. 31(6). 106328–106328.
2.
Shimoyama, Takashi, Ken Yoshida, Yoshinao Muro, et al.. (2024). Magnetic resonance imaging patterns revealing muscle pathology and clinical features in idiopathic inflammatory myopathies. Lara D. Veeken. 63(10). 2684–2693. 2 indexed citations
3.
Yoshida, Ken, Takeshi Fukuda, Taro Ukichi, et al.. (2023). Intramuscular lesions in musculoskeletal MRI as a favourable prognostic sign in patients with anti-MDA5 antibody-positive dermatomyositis. RMD Open. 9(3). e003271–e003271. 2 indexed citations
4.
Yoshida, Ken, Haruyasu Ito, Ryo Ikeda, et al.. (2023). Autocitrullination confers monocyte chemotactic properties to peptidylarginine deiminase 4. Scientific Reports. 13(1). 7528–7528. 2 indexed citations
5.
Kobayashi, Yohei, Naoki Takahashi, Eiichiro Nakagawa, et al.. (2023). Prognostic implications of post-discharge hemodynamic congestion assessed by peripheral venous pressure among patients discharged from acute heart failure. International Journal of Cardiology. 374. 58–64. 4 indexed citations
6.
Noda, Kentaro, et al.. (2023). Clinical features of newly diagnosed systemic lupus erythematosus after SARS-CoV-2 vaccination. Modern Rheumatology Case Reports. 8(1). 63–68. 1 indexed citations
8.
Noda, Kentaro, Bianca Dufner, Haruyasu Ito, et al.. (2021). Differential inflammation-mediated function of prokineticin 2 in the synovial fibroblasts of patients with rheumatoid arthritis compared with osteoarthritis. Scientific Reports. 11(1). 18399–18399. 10 indexed citations
9.
Nagao, Kazuya, Akinori Tamura, Takeshi Morimoto, et al.. (2017). Liver fibrogenesis marker, 7S domain of collagen type IV in patients with acutely decompensated heart failure: Correlates, prognostic value and time course. International Journal of Cardiology. 236. 483–487. 13 indexed citations
10.
Saitô, Saburô, et al.. (2017). Regulation of Th2 responses by different cell types expressing the interleukin-31 receptor. Allergy Asthma and Clinical Immunology. 13(1). 23–23. 15 indexed citations
11.
Yoshida, Ken, Haruyasu Ito, Kazuhiro Furuya, et al.. (2017). Angiogenesis and VEGF-expressing cells are identified predominantly in the fascia rather than in the muscle during the early phase of dermatomyositis. Arthritis Research & Therapy. 19(1). 272–272. 15 indexed citations
12.
Ito, Haruyasu, Kentaro Noda, Ken Yoshida, et al.. (2016). Prokineticin 2 antagonist, PKRA7 suppresses arthritis in mice with collagen-induced arthritis. BMC Musculoskeletal Disorders. 17(1). 387–387. 20 indexed citations
14.
Meguro, Akira, Masao Ôta, Mami Ishihara, et al.. (2012). Lack of association between IL10 polymorphisms and sarcoidosis in Japanese patients.. PubMed. 18. 512–8. 6 indexed citations
15.
Ito, Haruyasu, et al.. (2003). Pioglitazone, a Peroxisome Proliferator-Activated Receptor-γ Agonist, Attenuates Myocardial Ischemia/Reperfusion Injury in a Rat Model. Laboratory Investigation. 83(12). 1715–1721. 93 indexed citations
16.
Kishimoto, Chiharu, Keisuke Shioji, Haruyasu Ito, et al.. (2002). Evaluation of Arteriolar Hyalinosis of the Skin of Patients With Chronic Congestive Heart Failure.. Circulation Journal. 66(4). 382–384. 3 indexed citations
17.
Miyamoto, Tadashi, Akira Matsumori, Myung‐Woo Hwang, et al.. (2001). Therapeutic effects of FTY720, a new immunosuppressive agent, in a murine model of acute viral myocarditis. Journal of the American College of Cardiology. 37(6). 1713–1718. 29 indexed citations
18.
Sato, Yukihito, et al.. (1996). Elevated circulating levels of tumor necrosis factor in patients with mitral valve disease and ventricular septum defect. Heart and Vessels. 11(4). 218–220. 2 indexed citations
19.
Horiuchi, Toshiyuki, T. Nakamura, Hiromori Tsutsumi, et al.. (1996). A Case of Abnormal Hemoglobin (HbJ Cape Town) With High Serum Levels of HbA1c.. Nippon Ronen Igakkai Zasshi Japanese Journal of Geriatrics. 33(2). 110–115. 3 indexed citations
20.
Takahashi, Ryutaro, Jun Inoue, Haruyasu Ito, & Hiroki Hibino. (1993). Evening primrose oil and fish oil in non-insulin-dependent-diabetes. Prostaglandins Leukotrienes and Essential Fatty Acids. 49(2). 569–571. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026